| Literature DB >> 34739065 |
Yas Sanaiha1,2, Joseph Hadaya1,2, Esteban Aguayo1, Formosa Chen2, Peyman Benharash1.
Abstract
Importance: Diverticulitis of the colon is an increasingly prevalent disease with significant implications for patient quality of life and health system resource expenditure. Although several randomized clinical trials and meta-analyses of Hartman procedure (HP) and primary anastomosis and proximal diversion (PAPD) have found surgical equipoise, questions regarding the relative performance of these treatments when applied broadly remain. Objective: To examine use of and outcomes after urgent sigmoid colectomy with end colostomy (ie, HP) vs PAPD in management of complicated diverticulitis. Design, Setting, and Participants: This retrospective cross-sectional study was a multicenter, population-based examination of inpatient hospitalizations, not including long-term rehabilitation facilities, using data from the 2014 to 2017 Nationwide Readmissions Database. It was performed from November 2020 to January 2021. Included patients were adults admitted with acute diverticulitis requiring HP or PAPD within 48 hours of admission. Exposures: Undergoing HP vs PAPD. Main Outcomes and Measures: Inverse probability treatment analysis was used to compare outcomes, including index mortality, composite complications (ie, neurologic, infectious, and cardiovascular complications), length of stay, and readmissions within 90 days.Entities:
Mesh:
Year: 2021 PMID: 34739065 PMCID: PMC8571654 DOI: 10.1001/jamanetworkopen.2021.30674
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Patient and Hospital Characteristics
| Characteristic | Patients, No. (%) | ||
|---|---|---|---|
| Undergoing HP (n = 32 326) | Undergoing PAPD (n = 1800) | ||
|
| |||
| Age, median (IQR), y | 65 (54-74) | 60 (51-70) | <.001 |
| Sex | |||
| Women | 16 889 (52.2) | 897 (49.8) | .21 |
| Men | 15 437 (47.8) | 903 (50.2) | |
| Congestive heart failure | 3077 (9.5) | 99 (5.5) | .001 |
| Coronary artery disease | 3826 (11.8) | 152 (8.4) | .001 |
| Chronic pulmonary parenchymal disease | 5925 (18.3) | 232 (13.0) | <.001 |
| Pulmonary hypertension | 1876 (5.8) | 132 (7.3) | .11 |
| Peripheral vascular disease | 1380 (4.3) | 83 (4.6) | .61 |
| Hypertension | 16 394 (50.5) | 874 (49.1) | .45 |
| Diabetes | 4305 (13.3) | 244 (13.6) | .86 |
| Chronic kidney dysfunction | 2724 (8.4) | 89 (4.9) | <.001 |
| Chronic liver disease | 1173 (3.6) | 68.8 (3.8) | .78 |
| Coagulopathy | 1816 (5.6) | 51 (2.8) | <.001 |
| Multiorgan dysfunction | 11 514 (35.6) | 520 (28.9) | <.001 |
| Obesity | 5073 (15.7) | 299 (16.6) | .52 |
| Weight loss | 4475 (13.8) | 236 (13.1) | .59 |
| Electrolyte abnormalities | 14 370 (44.5) | 698 (38.8) | .004 |
| Peritonitis | 9.292 (28.7) | 242 (13.4) | <.001 |
| Ascites | 1243 (3.8) | 74 (4.1) | .71 |
| Chronic steroid use | 847 (2.6) | 26 (1.4) | .02 |
| Percutaneous drain | 1350 (4.2) | 83 (4.6) | .54 |
| Laparoscopy | 748 (2.3) | 37 (2.1) | .64 |
| Laparoscopic converted to open approach | 851 (2.6) | 90 (5.0) | .001 |
| Income quartile | |||
| 0-25th | 7859 (24.7) | 394 (22.2) | .19 |
| 25th-50th | 8891 (27.9) | 491 (27.7) | |
| 50th-75th | 8311 (26.1) | 445 (25.2) | |
| 75th-100th | 6831 (21.4) | 441 (24.9) | |
| Private insurer | 11 040 (34.2) | 795 (44.2) | <.001 |
|
| |||
| Teaching status | .36 | ||
| Metropolitan, nonteaching | 10 449 (32.3) | 548 (30.4) | .16 |
| Metropolitan, teaching | 18 243 (56.4) | 1073 (59.6) | |
| Rural | 3634 (11.2) | 179 (9.9) | |
| Safety net hospital status | 8464 (26.2) | 486 (27.0) | .68 |
| Interhospital transfer | 480 (1.5) | 23 (1.3) | .65 |
| Annual sigmoidectomy volume, median (IQR), No. operations performed | 26 (14-44) | 34 (18-57) | <.001 |
| Annual diverticulitis volume, median (IQR), No. hospital admissions | 150 (89-232) | 153 (95-241) | .25 |
Abbreviations: HP, Hartmann procedure; PAPD, primary anastomosis and diverting loop ileostomy.
Univariate Index and Readmission Outcomes
| Outcome | Patients, No. (%) | ||
|---|---|---|---|
| Undergoing HP | Undergoing PAPD | ||
| Final study cohort, No. | 32 326 | 1800 | NA |
| Mortality | 1475 (4.6) | 28 (1.5) | <.001 |
| Composite complication | 14 348 (44.4) | 634 (35.2) | <.001 |
| Stroke | 82 (0.3) | NA | NA |
| Myocardial infarction | 249 (0.8) | NA | NA |
| Cardiac arrest | 249 (0.8) | NA | NA |
| Pneumonia | 623 (1.9) | 24 (1.4) | .18 |
| Pulmonary embolism | 319 (1.0) | 15(0.9) | .67 |
| Acute respiratory failure | 4555(14.1) | 160 (9.0) | <.001 |
| Pulmonary edema | 146 (0.5) | NA | NA |
| Deep vein thrombosis | 2013 (0.6) | NA | NA |
| Prolonged ventilation | 1667 (5.2) | 55 (3.0) | .005 |
| Urinary tract infection | 2101 (6.5) | 108 (6.0) | .61 |
| Surgical site infection | 1125 (3.5) | 78 (4.3) | .24 |
| Sepsis | 10 222 (31.6) | 444 (24.7) | .0001 |
| Septicemia | 9784(30.3) | 396 (22.0) | <.001 |
| Hospitalization cost, median (IQR), $ | 24 139 (17 302-36 396) | 25 657 (18 082-36 362) | .01 |
| Hospitalization duration, median (IQR), d | 9 (7-12) | 8 (6-12) | .07 |
| Patients surviving index hospitalization, No. | 30 851 | 1772 | NA |
| Nonhome discharge | 8394 (27.3) | 332 (18.8) | <.001 |
| At 30 d | |||
| Readmission | 3416 (11.1) | 336 (19.0) | <.001 |
| Readmission mortality | 159 (4.6) | NA | NA |
| Cost, median (IQR), $ | 9567 (5728-17 096) | 8104 (4767-13 196) | .02 |
| Length of stay, median (IQR), d | 5 (3-8) | 5 (3-7) | .26 |
| At 31-90 d | |||
| Readmission | 1451 (4.7) | 122 (6.9) | .01 |
| Readmission mortality | 50 (3.4) | NA | NA |
| Cost, median (IQR), $ | 8917 (5358-16 598) | 9379 (5013-14 111) | .79 |
| Length of stay, median (IQR), d | 4 (3-7) | 4 (2-6) | .57 |
| Ostomy closure | 5983 (19.4) | 315(17.8) | .30 |
Abbreviations: HP, Hartmann procedure; NA, not applicable; PAPD, primary anastomosis and diverting loop ileostomy.
Cell sizes with 10 or fewer patients were censored and marked NA in accordance with Nationwide Readmissions Database requirements.
Prolonged ventilation was defined as more than 96 hours.
Figure 1. Probability of Freedom From Readmission by Operative Approach
Risk-adjusted freedom from nonelective readmission adjusting for patient and hospital characteristics using inverse probability treatment weights and Royston-Parmar flexible parametric models is presented.
Figure 2. Probability of Freedom From Ostomy Reversal by Operative Approach
Risk-adjusted hazard of ostomy closure adjusting for patient and hospital characteristics using inverse probability treatment weights and Royston-Parmar flexible parametric models is presented.